Product Images Taztia XT
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Taztia XT NDC 62037-696 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image 1
image 2
This is a description for Taztia XT® drug manufactured by Actavis Laboratories. Taztia XT® is an extended-release drug capsules that contain Diltiazem Hydrochloride, USP, that helps patients maintain regular heart rhythms. The capsules are taken orally, once a day. Each capsule contains 120 mg of Diltiazem Hydrochloride, USP. The drug should be stored in tight containers with safety closures and kept out of the reach of children at a temperature between 20°C to 25°C. For full prescribing information, see insert. The drug is distributed by Actavis Pharma, Inc. in Parsippany, NJ.*
image 3
NDC 62037-697-30 is a prescription drug consisting of Diltiazem Hydrochloride, USP with a dosage of 180 mg. The medication should be stored in a tightly sealed container with safety closures at a controlled room temperature between 20°C to 25°C. It is recommended to keep the medication away from children. The dosage regimen involves administering once a day. This text seems to be a prescribing insert for the medication.*
image 4
This is a medication called Taztia XT® (Diltiazem HCI Extended-Release Capsules), which is a once-a-day dosage. It comes in a package containing 30 capsules, each containing 240 mg of Diltiazem Hydrochloride, USP. The usual dosage recommended is to administer once daily. The medication should be stored in tight containers with safety closures, and at a controlled room temperature. It is distributed by Actavis Pharma, Inc. and manufactured by Actavis Laboratories FL Inc in Fort Lauderdale, USA.*
image 5
Taztia XT® is a medication used for once-a-day dosage for extended-release capsules, USP that contains 300mg of Diltiazem hydrochloride. This medication should be kept in tight containers with safety closures and should be stored at 20° to 25°C [See USP Controlled Room Temperature]. The usual dosage is to administer once daily. This medication is manufactured by Actavis Laboratories FL, Inc, Fort Lauderdale, FL 33314 USA, and distributed by Actavis Pharma, Inc, Parsippany, NJ 07054 USA. For more information, see the insert for full prescribing information. Keep this and all medication out of reach of children.*
image 6
This is a description of Taztia XT, which is a once-a-day dosage of Diltiazem HCI Extended-Release Capsules. Each capsule contains 360mg of Diltiazem Hydrochloride, which is a medication used to treat high blood pressure and chest pain caused by reduced blood flow to the heart. The medication should be kept in a secure container to prevent children from accessing it, and the usual dosage is one capsule per day. Specific instructions for use should be found in the insert, and it should be stored at room temperature. It is manufactured by Actavis Laboratories and distributed by Actavis Pharma.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.